Presentations
The information contained in the presentations listed below is provided for historical purposes only and may not be accurate as of the date such presentations are viewed. We do not undertake to update the below presentations to reflect the impact of circumstances or events that may arise after the date of such presentations.
Cocrystal Pharma Highlights its Novel Inhaled and Oral Influenza A Antiviral CC-42344 at the World Vaccine Congress West Coast
First-in-Human Study of CC-42344, A Novel Broad-Spectrum Influenza A Polymerase PB2 Inhibitor 7th Annual ISIRV-AVG Conference
World Antiviral Congress Presentation
Discovery of Potent, Broad-Spectrum SARS-CoV Mpro Inhibitors: Advancing to Clinical Development
